1461 related articles for article (PubMed ID: 15300587)
1. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
2. Central pre-proglucagon derived peptides: opportunities for treatment of obesity.
Larsen PJ; Vrang N; Tang-Christensen M
Curr Pharm Des; 2003; 9(17):1373-82. PubMed ID: 12769729
[TBL] [Abstract][Full Text] [Related]
3. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
Maida A; Lovshin JA; Baggio LL; Drucker DJ
Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
[TBL] [Abstract][Full Text] [Related]
4. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Diabetes; 2004 Sep; 53(9):2492-500. PubMed ID: 15331566
[TBL] [Abstract][Full Text] [Related]
5. Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor.
Sowden GL; Drucker DJ; Weinshenker D; Swoap SJ
Am J Physiol Regul Integr Comp Physiol; 2007 Feb; 292(2):R962-70. PubMed ID: 17038440
[TBL] [Abstract][Full Text] [Related]
6. Peripheral oxyntomodulin reduces food intake and body weight gain in rats.
Dakin CL; Small CJ; Batterham RL; Neary NM; Cohen MA; Patterson M; Ghatei MA; Bloom SR
Endocrinology; 2004 Jun; 145(6):2687-95. PubMed ID: 15001546
[TBL] [Abstract][Full Text] [Related]
7. Effects of glucagon-like peptide 1 and oxyntomodulin on neuronal activity of ghrelin-sensitive neurons in the hypothalamic arcuate nucleus.
Riediger T; Eisele N; Scheel C; Lutz TA
Am J Physiol Regul Integr Comp Physiol; 2010 Apr; 298(4):R1061-7. PubMed ID: 20147608
[TBL] [Abstract][Full Text] [Related]
8. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.
Barrera JG; D'Alessio DA; Drucker DJ; Woods SC; Seeley RJ
Diabetes; 2009 Dec; 58(12):2820-7. PubMed ID: 19741167
[TBL] [Abstract][Full Text] [Related]
9. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.
Burmeister MA; Ayala J; Drucker DJ; Ayala JE
Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E677-85. PubMed ID: 23341495
[TBL] [Abstract][Full Text] [Related]
10. Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling.
Lockie SH; Heppner KM; Chaudhary N; Chabenne JR; Morgan DA; Veyrat-Durebex C; Ananthakrishnan G; Rohner-Jeanrenaud F; Drucker DJ; DiMarchi R; Rahmouni K; Oldfield BJ; Tschöp MH; Perez-Tilve D
Diabetes; 2012 Nov; 61(11):2753-62. PubMed ID: 22933116
[TBL] [Abstract][Full Text] [Related]
11. Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide, oxyntomodulin, exendin-4, and exendin(9-39).
Fehmann HC; Jiang J; Schweinfurth J; Wheeler MB; Boyd AE; Göke B
Peptides; 1994; 15(3):453-6. PubMed ID: 7937318
[TBL] [Abstract][Full Text] [Related]
12. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
[TBL] [Abstract][Full Text] [Related]
13. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
Baggio LL; Huang Q; Cao X; Drucker DJ
Gastroenterology; 2008 Apr; 134(4):1137-47. PubMed ID: 18313669
[TBL] [Abstract][Full Text] [Related]
14. Glucagon and glucagon-like peptide receptors as drug targets.
Estall JL; Drucker DJ
Curr Pharm Des; 2006; 12(14):1731-50. PubMed ID: 16712485
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding-associated neuropeptides in hypothalamic neurons in vivo and in vitro.
Dalvi PS; Nazarians-Armavil A; Purser MJ; Belsham DD
Endocrinology; 2012 May; 153(5):2208-22. PubMed ID: 22334721
[TBL] [Abstract][Full Text] [Related]
16. Novel glucagon- and OXM-based peptides acting through glucagon and GLP-1 receptors with body weight reduction and anti-diabetic properties.
Cai X; Li C; Zhou J; Dai Y; Avraham Y; Sun L; Liu C; Tong J; Wang Y; Bi X; He L; Huang W; Qian H
Bioorg Chem; 2020 Jan; 95():103538. PubMed ID: 31901754
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line.
Gros L; Thorens B; Bataille D; Kervran A
Endocrinology; 1993 Aug; 133(2):631-8. PubMed ID: 8102095
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites.
Yamamoto H; Kishi T; Lee CE; Choi BJ; Fang H; Hollenberg AN; Drucker DJ; Elmquist JK
J Neurosci; 2003 Apr; 23(7):2939-46. PubMed ID: 12684481
[TBL] [Abstract][Full Text] [Related]
19. Chronic exposure to GLP-1R agonists promotes homologous GLP-1 receptor desensitization in vitro but does not attenuate GLP-1R-dependent glucose homeostasis in vivo.
Baggio LL; Kim JG; Drucker DJ
Diabetes; 2004 Dec; 53 Suppl 3():S205-14. PubMed ID: 15561912
[TBL] [Abstract][Full Text] [Related]
20. A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties.
Bhat VK; Kerr BD; Flatt PR; Gault VA
Biochem Pharmacol; 2013 Jun; 85(11):1655-62. PubMed ID: 23518155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
